Network origin in Andrew Nebel first degree
Entity | Entity type | Industry | |
---|---|---|---|
Duchenne UK
Duchenne UK Investment Trusts/Mutual FundsMiscellaneous Duchenne UK is a UK-based charity that focuses on finding effective treatments for Duchenne muscular dystrophy (DMD), a progressive condition that weakens all the muscles in the body and is diagnosed in childhood. Additionally, Duchenne connects and supports families affected by DMD. The charity funds research that aims to provide treatments for those affected by DMD and removes roadblocks that prevent patients from accessing the treatments they need. The British company was founded in 2012 by Nick Crossley, Emily Crossley, and Alex Johnson, and Emily Crossley and Alex Johnson have been the CEOs since 2012.
10
| Non-Profit Organization | Investment Trusts/Mutual Funds | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Andrew Nebel via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Duchenne Research (UK) Investment Ltd.
Duchenne Research (UK) Investment Ltd. BiotechnologyHealth Technology Duchenne Research (UK) Investment Ltd. is a biotechnology research and British experimental development company founded in 2014. The location of the private company is not specified. The company provides services in the field of biotechnology research and development. | Biotechnology | Director/Board Member |
Statistics
International
United Kingdom | 2 |
Sectoral
Health Technology | 2 |
Operational
Director/Board Member | 9 |
Founder | 3 |
Chief Executive Officer | 2 |
Most connected contacts
- Stock Market
- Insiders
- Andrew Nebel
- Company connections